Idera Pharma (Comparative Multiple Analysis)
Improve your investment analysis with by seeing the Idera Pharma's Discounted Cash Flow analysis, Idera Pharma's Warren Buffet analysis, and Idera Pharma's Weighted Average Cost of Capital (WACC) Analysis.
Notes on the Comparative Multiple Analysis of Idera Pharma
WikiWealth compares Idera Pharma's revenue, EBITDA, and EBIT multiples to their peers in order to determine the appropriate fair valuation. Click in the top right corner to experiment with Idera Pharma's comparative analysis.
Notes from the analysis:
1. WikiWealth uses quantitative measures to determine the multiple range for Idera Pharma.
Helpful Information for Idera Pharma's Analysis
How does this work? The Comparative Investment Analysis determines the value of Idera Pharma by comparing Idera Pharma financial ratios, prices, growth rates, margins, etc. to those of relevant peer groups.
Value Investing Importance? This method is widely used by investment professionals to determine the correct price of investments, especially initial public offerings (IPOs). It is one element of WikiWealth's three Wall Street approaches used to determine the correct fair value of Idera Pharma.
Also, see the Idera Pharma's buffett intrinsic valuation analysis for WikiWealth's attempt to replicate the investing formula's used by Warren Buffett and Idera Pharma's valuation conclusion for a quick summary.